Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 2002 Jul 15;365(Pt 2):505–511. doi: 10.1042/BJ20011648

Total direct chemical synthesis and biological activities of human group IIA secretory phospholipase A2.

Chang-Zhi Dong 1, Anthony Romieu 1, Carine M Mounier 1, Françoise Heymans 1, Bernard P Roques 1, Jean-Jacques Godfroid 1
PMCID: PMC1222685  PMID: 11936952

Abstract

Human group IIA secretory phospholipase A(2) (hGIIA sPLA(2)) is reported to be involved in inflammation, since its expression level is enhanced under various inflammatory conditions. In this work, we report the total chemical synthesis of this enzyme (124 amino acids) by solid-phase method. The identity of the protein, in denatured or folded (7 disulphide bonds) forms, was confirmed by electrospray MS. Synthetic sPLA(2) possesses the same circular dichroism spectrum, enzymic activity in hydrolysing different phospholipid substrates, and inhibitory effect in thrombin formation from prothrombinase complex as the recombinant sPLA(2). Furthermore, LY311727, a reported specific hGIIA sPLA(2) inhibitor, is able to inhibit the synthetic and the recombinant enzymes with the same efficiency. This study demonstrates that chemically continuous solid phase synthesis is an alternative and less time-consuming approach to producing small, structurally folded and fully active proteins of up to 124 amino acids, such as hGIIA sPLA(2). Moreover, this technique provides more flexibility in analogue synthesis to elucidate their physiological functions and pathological effects.

Full Text

The Full Text of this article is available as a PDF (166.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asaoka Y., Yoshida K., Sasaki Y., Nishizuka Y., Murakami M., Kudo I., Inoue K. Possible role of mammalian secretory group II phospholipase A2 in T-lymphocyte activation: implication in propagation of inflammatory reaction. Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):716–719. doi: 10.1073/pnas.90.2.716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Atsumi G., Murakami M., Tajima M., Shimbara S., Hara N., Kudo I. The perturbed membrane of cells undergoing apoptosis is susceptible to type II secretory phospholipase A2 to liberate arachidonic acid. Biochim Biophys Acta. 1997 Nov 8;1349(1):43–54. doi: 10.1016/s0005-2760(97)00082-9. [DOI] [PubMed] [Google Scholar]
  3. Bezzine S., Koduri R. S., Valentin E., Murakami M., Kudo I., Ghomashchi F., Sadilek M., Lambeau G., Gelb M. H. Exogenously added human group X secreted phospholipase A(2) but not the group IB, IIA, and V enzymes efficiently release arachidonic acid from adherent mammalian cells. J Biol Chem. 2000 Feb 4;275(5):3179–3191. doi: 10.1074/jbc.275.5.3179. [DOI] [PubMed] [Google Scholar]
  4. Cho W. Structure, function, and regulation of group V phospholipase A(2). Biochim Biophys Acta. 2000 Oct 31;1488(1-2):48–58. doi: 10.1016/s1388-1981(00)00109-8. [DOI] [PubMed] [Google Scholar]
  5. Cornille F., Goudreau N., Ficheux D., Niemann H., Roques B. P. Solid-phase synthesis, conformational analysis and in vitro cleavage of synthetic human synaptobrevin II 1-93 by tetanus toxin L chain. Eur J Biochem. 1994 May 15;222(1):173–181. doi: 10.1111/j.1432-1033.1994.tb18855.x. [DOI] [PubMed] [Google Scholar]
  6. Cornille F., Wecker K., Loffet A., Genet R., Roques B. Efficient solid-phase synthesis of Vpr from HIV-1 using low quantities of uniformly 13C-, 15N-labeled amino acids for NMR structural studies. J Pept Res. 1999 Nov;54(5):427–435. doi: 10.1034/j.1399-3011.1999.00129.x. [DOI] [PubMed] [Google Scholar]
  7. Dawson P. E., Kent S. B. Synthesis of native proteins by chemical ligation. Annu Rev Biochem. 2000;69:923–960. doi: 10.1146/annurev.biochem.69.1.923. [DOI] [PubMed] [Google Scholar]
  8. De Rocquigny H., Gabus C., Vincent A., Fournié-Zaluski M. C., Roques B., Darlix J. L. Viral RNA annealing activities of human immunodeficiency virus type 1 nucleocapsid protein require only peptide domains outside the zinc fingers. Proc Natl Acad Sci U S A. 1992 Jul 15;89(14):6472–6476. doi: 10.1073/pnas.89.14.6472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dong C. Z., De Rocquigny H., Rémy E., Mellac S., Fournié-Zaluski M. C., Roques B. P. Synthesis and biological activities of fluorescent acridine-containing HIV-1 nucleocapsid proteins for investigation of nucleic acid-NCp7 interactions. J Pept Res. 1997 Oct;50(4):269–278. doi: 10.1111/j.1399-3011.1997.tb01468.x. [DOI] [PubMed] [Google Scholar]
  10. Gelb M. H., Min J. H., Jain M. K. Do membrane-bound enzymes access their substrates from the membrane or aqueous phase: interfacial versus non-interfacial enzymes. Biochim Biophys Acta. 2000 Oct 31;1488(1-2):20–27. doi: 10.1016/s1388-1981(00)00106-2. [DOI] [PubMed] [Google Scholar]
  11. Gelb M. H., Valentin E., Ghomashchi F., Lazdunski M., Lambeau G. Cloning and recombinant expression of a structurally novel human secreted phospholipase A2. J Biol Chem. 2000 Dec 22;275(51):39823–39826. doi: 10.1074/jbc.C000671200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hackeng T. M., Griffin J. H., Dawson P. E. Protein synthesis by native chemical ligation: expanded scope by using straightforward methodology. Proc Natl Acad Sci U S A. 1999 Aug 31;96(18):10068–10073. doi: 10.1073/pnas.96.18.10068. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hackeng T. M., Mounier C. M., Bon C., Dawson P. E., Griffin J. H., Kent S. B. Total chemical synthesis of enzymatically active human type II secretory phospholipase A2. Proc Natl Acad Sci U S A. 1997 Jul 22;94(15):7845–7850. doi: 10.1073/pnas.94.15.7845. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hanasaki K., Ono T., Saiga A., Morioka Y., Ikeda M., Kawamoto K., Higashino K., Nakano K., Yamada K., Ishizaki J. Purified group X secretory phospholipase A(2) induced prominent release of arachidonic acid from human myeloid leukemia cells. J Biol Chem. 1999 Nov 26;274(48):34203–34211. doi: 10.1074/jbc.274.48.34203. [DOI] [PubMed] [Google Scholar]
  15. Kishino J., Ohara O., Nomura K., Kramer R. M., Arita H. Pancreatic-type phospholipase A2 induces group II phospholipase A2 expression and prostaglandin biosynthesis in rat mesangial cells. J Biol Chem. 1994 Feb 18;269(7):5092–5098. [PubMed] [Google Scholar]
  16. Loo J. A., Edmonds C. G., Udseth H. R., Smith R. D. Effect of reducing disulfide-containing proteins on electrospray ionization mass spectra. Anal Chem. 1990 Apr 1;62(7):693–698. doi: 10.1021/ac00206a009. [DOI] [PubMed] [Google Scholar]
  17. Mounier C. M., Hackeng T. M., Schaeffer F., Faure G., Bon C., Griffin J. H. Inhibition of prothrombinase by human secretory phospholipase A2 involves binding to factor Xa. J Biol Chem. 1998 Sep 11;273(37):23764–23772. doi: 10.1074/jbc.273.37.23764. [DOI] [PubMed] [Google Scholar]
  18. Mounier C. M., Luchetta P., Lecut C., Koduri R. S., Faure G., Lambeau G., Valentin E., Singer A., Ghomashchi F., Béguin S. Basic residues of human group IIA phospholipase A2 are important for binding to factor Xa and prothrombinase inhibition comparison with other mammalian secreted phospholipases A2. Eur J Biochem. 2000 Aug;267(16):4960–4969. doi: 10.1046/j.1432-1327.2000.01523.x. [DOI] [PubMed] [Google Scholar]
  19. Mounier C., Franken P. A., Verheij H. M., Bon C. The anticoagulant effect of the human secretory phospholipase A2 on blood plasma and on a cell-free system is due to a phospholipid-independent mechanism of action involving the inhibition of factor Va. Eur J Biochem. 1996 May 1;237(3):778–785. doi: 10.1111/j.1432-1033.1996.0778p.x. [DOI] [PubMed] [Google Scholar]
  20. Murakami M., Kambe T., Shimbara S., Yamamoto S., Kuwata H., Kudo I. Functional association of type IIA secretory phospholipase A(2) with the glycosylphosphatidylinositol-anchored heparan sulfate proteoglycan in the cyclooxygenase-2-mediated delayed prostanoid-biosynthetic pathway. J Biol Chem. 1999 Oct 15;274(42):29927–29936. doi: 10.1074/jbc.274.42.29927. [DOI] [PubMed] [Google Scholar]
  21. Murakami M., Koduri R. S., Enomoto A., Shimbara S., Seki M., Yoshihara K., Singer A., Valentin E., Ghomashchi F., Lambeau G. Distinct arachidonate-releasing functions of mammalian secreted phospholipase A2s in human embryonic kidney 293 and rat mastocytoma RBL-2H3 cells through heparan sulfate shuttling and external plasma membrane mechanisms. J Biol Chem. 2000 Dec 5;276(13):10083–10096. doi: 10.1074/jbc.M007877200. [DOI] [PubMed] [Google Scholar]
  22. Schevitz R. W., Bach N. J., Carlson D. G., Chirgadze N. Y., Clawson D. K., Dillard R. D., Draheim S. E., Hartley L. W., Jones N. D., Mihelich E. D. Structure-based design of the first potent and selective inhibitor of human non-pancreatic secretory phospholipase A2. Nat Struct Biol. 1995 Jun;2(6):458–465. doi: 10.1038/nsb0695-458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Six D. A., Dennis E. A. The expanding superfamily of phospholipase A(2) enzymes: classification and characterization. Biochim Biophys Acta. 2000 Oct 31;1488(1-2):1–19. doi: 10.1016/s1388-1981(00)00105-0. [DOI] [PubMed] [Google Scholar]
  24. Valentin E., Lambeau G. Increasing molecular diversity of secreted phospholipases A(2) and their receptors and binding proteins. Biochim Biophys Acta. 2000 Oct 31;1488(1-2):59–70. doi: 10.1016/s1388-1981(00)00110-4. [DOI] [PubMed] [Google Scholar]
  25. Wilson H. A., Waldrip J. B., Nielson K. H., Judd A. M., Han S. K., Cho W., Sims P. J., Bell J. D. Mechanisms by which elevated intracellular calcium induces S49 cell membranes to become susceptible to the action of secretory phospholipase A2. J Biol Chem. 1999 Apr 23;274(17):11494–11504. doi: 10.1074/jbc.274.17.11494. [DOI] [PubMed] [Google Scholar]
  26. Yan L. Z., Dawson P. E. Synthesis of peptides and proteins without cysteine residues by native chemical ligation combined with desulfurization. J Am Chem Soc. 2001 Jan 31;123(4):526–533. doi: 10.1021/ja003265m. [DOI] [PubMed] [Google Scholar]
  27. de Rocquigny H., Petitjean P., Tanchou V., Decimo D., Drouot L., Delaunay T., Darlix J. L., Roques B. P. The zinc fingers of HIV nucleocapsid protein NCp7 direct interactions with the viral regulatory protein Vpr. J Biol Chem. 1997 Dec 5;272(49):30753–30759. doi: 10.1074/jbc.272.49.30753. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES